ARCHETYPE REACH-B score (openEHR-EHR-OBSERVATION.reach_b.v0)

ARCHETYPE IDopenEHR-EHR-OBSERVATION.reach_b.v0
ConceptREACH-B score
DescriptionAn assessment score used to estimate risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B.
UseUse to record the results for each component parameter and their total sum for the REACH-B score.
PurposeTo record the results for each component parameter and their total sum for the REACH-B score.
References1. Yang HI, Yuen MF, Chan HL, Han KH, Chen PJ, Kim DY, Ahn SH, Chen CJ, Wong VW, Seto WK; REACH-B Working Group. Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score. Lancet Oncol. 2011 Jun;12(6):568-74. doi: 10.1016/S1470-2045(11)70077-8. Epub 2011 Apr 14. PMID: 21497551.
Copyright© Cambio CDS, openEHR Foundation
AuthorsAuthor name: Maryam Razavi
Organisation: Cambio CDS
Email: maryam.razavi@cambio.se
Date originally authored: 2020-12-15
Other Details LanguageAuthor name: Maryam Razavi
Organisation: Cambio CDS
Email: maryam.razavi@cambio.se
Date originally authored: 2020-12-15
Other Details (Language Independent)
  • Licence: This work is licensed under the Creative Commons Attribution-ShareAlike 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-sa/4.0/.
  • Custodian Organisation: openEHR Foundation
  • References: 1. Yang HI, Yuen MF, Chan HL, Han KH, Chen PJ, Kim DY, Ahn SH, Chen CJ, Wong VW, Seto WK; REACH-B Working Group. Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score. Lancet Oncol. 2011 Jun;12(6):568-74. doi: 10.1016/S1470-2045(11)70077-8. Epub 2011 Apr 14. PMID: 21497551.
  • Current Contact: maryam.razavi@cambio.se
  • Original Namespace: org.openehr
  • Original Publisher: openEHR Foundation
  • Custodian Namespace: org.openehr
  • MD5-CAM-1.0.1: 949E232088D2F83CC417F71212782AF1
  • Build Uid: 7b1a61e8-a015-4c83-ac8d-0b0f67a52478
  • Revision: 0.0.1-alpha
KeywordsHCC, hepatitis, HBeAg, ALT, carcinoma, hepatocellular
Lifecyclein_development
UIDf47d79bc-e33c-41f0-9c3d-88d5e641d60a
Language useden
Citeable Identifier1246.145.2948
Revision Number0.0.1-alpha
data
SexSex: *
0: Female [*]
2: Male [*]
Age (years)Age (years): *
0: 30–34 [*]
1: 35–39 [*]
2: 40–44 [*]
3: 45–49 [*]
4: 50–54 [*]
5: 55–59 [*]
6: 60–65 [*]
ALT (U/L)ALT (U/L): Alanine aminotransferase (ALT)
0: <15 [*]
1: 15-44 [*]
2: ≥45 [*]
HBeAgHBeAg: hepatitis B e-antigen
0: Negative [*]
2: Positive [*]
Hepatitis B virus DNA level (copies/mL)Hepatitis B virus DNA level (copies/mL): *
0: <300 (undetectable) [*]
0: 300–9,999 [*]
3: 10,000–99,999 [*]
4: ≥10⁶ [*]
5: 100,000–999,999 [*]
Total scoreTotal score: *
min: >=0; max: <=17

events
Any eventAny event: *
Other contributors
Translators